BAKER BROS ADVISORS LLC Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for BAKER BROS ADVISORS LLC.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of BAKER BROS ADVISORS LLC. BAKER BROS ADVISORS LLC is a 10% Owner in BIOCRYST PHARMACEUTICALS INC ($BCRX) and a Director in INCYTE CORP ($INCY) and a Director in ALEXION PHARMACEUTICALS INC ($ALXN) and a Director in IDERA PHARMACEUTICALS, INC. ($IDRA) and a in XOMA Corp ($XOMA) and a Director in ACADIA PHARMACEUTICALS INC ($ACAD) and a Director in SEATTLE GENETICS INC /WA ($SGEN) and a Director in GENOMIC HEALTH INC ($GHDX) and a 10% Owner in BELLICUM PHARMACEUTICALS, INC ($BLCM) and a 10% Owner in AQUINOX PHARMACEUTICALS, INC ($AQXP) and a Director in AQUINOX PHARMACEUTICALS, INC ($AQXP) and a Director in Kodiak Sciences Inc. ($KOD) and a 10% Owner in Invitae Corp ($NVTA) and a in Mirati Therapeutics, Inc. ($MYG) and a 10% Owner in Mirati Therapeutics, Inc. ($MYG) and a in RHYTHM PHARMACEUTICALS, INC. ($RYTM) and a in Intellia Therapeutics, Inc. ($NTLA) and a Director in BeiGene, Ltd. ($BGNE) and a Director in Kiniksa Pharmaceuticals, Ltd. ($KNSA).

Over the past year BAKER BROS ADVISORS LLC has been an insider in 12 companies. The total value of shares held by BAKER BROS ADVISORS LLC in these companies amounts to $1,172,764,239.

BAKER BROS ADVISORS LLC Director
ACADIA PHARMACEUTICALS INC
Director
ALEXION PHARMACEUTICALS, INC.
Director, 10% Owner
AQUINOX PHARMACEUTICALS, INC
Director
BeiGene, Ltd.
10% Owner
BELLICUM PHARMACEUTICALS, INC
10% Owner
BIOCRYST PHARMACEUTICALS INC
Director
GENOMIC HEALTH INC
Director
IDERA PHARMACEUTICALS, INC.
Director
INCYTE CORP
Intellia Therapeutics, Inc.
10% Owner
Invitae Corp
Director
Kiniksa Pharmaceuticals, Ltd.
Director
Kodiak Sciences Inc.
Mirati Therapeutics, Inc.
RHYTHM PHARMACEUTICALS, INC.
Director
SEATTLE GENETICS INC /WA
XOMA Corp
$ 1172764239 The total value of shares held by BAKER BROS ADVISORS LLC
Insider Rank

BAKER BROS ADVISORS LLC ranks 102 out of 350,000 insiders. Go to Insider Ranking to see more.

Address: 667 MADISON AVENUE 21ST FLOOR NEW YORK US 10065 NY

Companies in which BAKER BROS ADVISORS LLC is an Insider

ACADIA PHARMACEUTICALS INC

Trading Symbol: ACAD
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of BAKER BROS ADVISORS LLC: Director
Holdings: 3,736,902 shares
Current Value: $142,712,287
Latest Transaction: Dec 04 2018
$ACAD Market Capitalization: $4.67B
$ACAD Previous Close: $38.19

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 33x
Sell: 3x
Shares Bought: 17,336,863
Shares Sold: 547,375
Share Difference: +16,789,488
Value Difference: -$304,892,284

ALEXION PHARMACEUTICALS, INC.

Trading Symbol: ALXN
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of BAKER BROS ADVISORS LLC: Director
Holdings: 982,320 shares
Current Value: $125,461,910
Latest Transaction: May 11 2018
$ALXN Market Capitalization: $28.30B
$ALXN Previous Close: $127.72

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 30x
Sell: 0x
Shares Bought: 1,357,363
Shares Sold: 0
Share Difference: +1,357,363
Value Difference: -$156,915,232

AQUINOX PHARMACEUTICALS, INC

Trading Symbol: AQXP
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of BAKER BROS ADVISORS LLC: Director, 10% Owner
Holdings: 1,132,228 shares
Current Value: $21,297,209
Latest Transaction: May 09 2018
$AQXP Market Capitalization: $451.60M
$AQXP Previous Close: $18.81

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 33x
Sell: 0x
Shares Bought: 3,653,334
Shares Sold: 0
Share Difference: +3,653,334
Value Difference: -$44,717,901

BeiGene, Ltd.

Trading Symbol: BGNE
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of BAKER BROS ADVISORS LLC: Director
Holdings: 600,791 shares
Current Value: $21,580,413
Latest Transaction: Aug 06 2018
$BGNE Market Capitalization: $1.14B
$BGNE Previous Close: $35.92

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 12x
Sell: 1x
Shares Bought: 9,782,213
Shares Sold: 49,200
Share Difference: +9,733,013
Value Difference: -$896,758,632

BELLICUM PHARMACEUTICALS, INC

Trading Symbol: BLCM
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of BAKER BROS ADVISORS LLC: 10% Owner
Holdings: 412,246 shares
Current Value: $5,181,932
Latest Transaction: Jan 19 2018
$BLCM Market Capitalization: $335.83M
$BLCM Previous Close: $12.57

Last 4 weeks trend: STRONG SELL
Last 3 months trend: STRONG SELL View transactions

Last 3 Months Overview:
Buy: 2x
Sell: 9x
Shares Bought: 166,666
Shares Sold: 880,735
Share Difference: -714,069
Value Difference: +$5,219,903

BIOCRYST PHARMACEUTICALS INC

Trading Symbol: BCRX
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of BAKER BROS ADVISORS LLC: 10% Owner
Holdings: 1,656,688 shares
Current Value: $9,393,421
Latest Transaction: Aug 16 2016
$BCRX Market Capitalization: $427.06M
$BCRX Previous Close: $5.67

Last 4 weeks trend: STRONG SELL
Last 3 months trend: STRONG SELL View transactions

Last 3 Months Overview:
Buy: 0x
Sell: 8x
Shares Bought: 0
Shares Sold: 4,046,590
Share Difference: -4,046,590
Value Difference: +$20,251,102

GENOMIC HEALTH INC

Trading Symbol: GHDX
Industry: SERVICES-MEDICAL LABORATORIES [8071]
Position of BAKER BROS ADVISORS LLC: Director
Holdings: 206,748 shares
Current Value: $5,683,503
Latest Transaction: Dec 12 2018
$GHDX Market Capitalization: $928.37M
$GHDX Previous Close: $27.49

Last 4 weeks trend: STRONG SELL
Last 3 months trend: STRONG SELL View transactions

Last 3 Months Overview:
Buy: 36x
Sell: 306x
Shares Bought: 110,616
Shares Sold: 2,047,244
Share Difference: -1,936,628
Value Difference: +$158,547,886

IDERA PHARMACEUTICALS, INC.

Trading Symbol: IDRA
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of BAKER BROS ADVISORS LLC: Director
Holdings: 518,905 shares
Current Value: $809,492
Latest Transaction: Oct 03 2018
$IDRA Market Capitalization: $230.34M
$IDRA Previous Close: $1.56

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 23x
Sell: 0x
Shares Bought: 28,500,500
Shares Sold: 0
Share Difference: +28,500,500
Value Difference: -$21,925,191

INCYTE CORP

Trading Symbol: INCY
Industry: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
Position of BAKER BROS ADVISORS LLC: Director
Holdings: 4,407,691 shares
Current Value: $520,900,922
Latest Transaction: Jul 03 2018
$INCY Market Capitalization: $23.12B
$INCY Previous Close: $118.18

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 18x
Sell: 0x
Shares Bought: 162,445
Shares Sold: 0
Share Difference: +162,445
Value Difference: -$13,863,160

Intellia Therapeutics, Inc.

Trading Symbol: NTLA
Industry: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
Position of BAKER BROS ADVISORS LLC:
Holdings: 976,214 shares
Current Value: $12,983,646
Latest Transaction: May 11 2016
$NTLA Market Capitalization: $471.17M
$NTLA Previous Close: $13.30

Last 4 weeks trend: HOLD
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 4x
Sell: 0x
Shares Bought: 1,062,120
Shares Sold: 0
Share Difference: +1,062,120
Value Difference: -$3,600,000

Invitae Corp

Trading Symbol: NVTA
Industry: SERVICES-MEDICAL LABORATORIES [8071]
Position of BAKER BROS ADVISORS LLC: 10% Owner
Holdings: 845,858 shares
Current Value: $7,443,550
Latest Transaction: Mar 29 2018
$NVTA Market Capitalization: $281.95M
$NVTA Previous Close: $8.80

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 4x
Sell: 0x
Shares Bought: 1,844,444
Shares Sold: 0
Share Difference: +1,844,444
Value Difference: -$9,399,998

Kiniksa Pharmaceuticals, Ltd.

Trading Symbol: KNSA
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of BAKER BROS ADVISORS LLC: Director
Holdings: 299,403 shares
Latest Transaction: May 31 2018

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 2x
Sell: 0x
Shares Bought: 3,000,000
Shares Sold: 0
Share Difference: +3,000,000
Value Difference: -$54,000,000

Kodiak Sciences Inc.

Trading Symbol: KOD
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of BAKER BROS ADVISORS LLC: Director
Holdings: 372,792 shares
Latest Transaction: Oct 11 2018

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 8x
Sell: 0x
Shares Bought: 9,145,115
Shares Sold: 0
Share Difference: +9,145,115
Value Difference: -$28,955,936

Mirati Therapeutics, Inc.

Trading Symbol: MYG
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of BAKER BROS ADVISORS LLC:
Holdings: 141,244 shares
Latest Transaction: Nov 20 2017

Last 4 weeks trend: STRONG SELL
Last 3 months trend: STRONG SELL View transactions

Last 3 Months Overview:
Buy: 7x
Sell: 12x
Shares Bought: 594,019
Shares Sold: 999,358
Share Difference: -405,339
Value Difference: +$5,084,890

RHYTHM PHARMACEUTICALS, INC.

Trading Symbol: RYTM
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of BAKER BROS ADVISORS LLC:
Holdings: 82,969 shares
Latest Transaction: Oct 06 2017

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 4x
Sell: 0x
Shares Bought: 2,049,020
Shares Sold: 0
Share Difference: +2,049,020
Value Difference: -$15,045,000

SEATTLE GENETICS INC /WA

Trading Symbol: SGEN
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of BAKER BROS ADVISORS LLC: Director
Holdings: 5,291,874 shares
Current Value: $321,693,020
Latest Transaction: May 18 2018
$SGEN Market Capitalization: $8.71B
$SGEN Previous Close: $60.79

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 28x
Sell: 0x
Shares Bought: 5,361,604
Shares Sold: 0
Share Difference: +5,361,604
Value Difference: -$277,147,212

XOMA Corp

Trading Symbol: XOMA
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of BAKER BROS ADVISORS LLC:
Holdings: 90,538 shares
Current Value: $381,165
Latest Transaction: Jul 23 2015
$XOMA Market Capitalization: $25.10M
$XOMA Previous Close: $4.21

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Latest Insider Trading Transactions of BAKER BROS ADVISORS LLC

Sentiment: All, ACAD, ALXN, AQXP, BGNE, BLCM, BCRX, GHDX, IDRA, INCY, NTLA, NVTA, KNSA, KOD, MYG, RYTM, SGEN, XOMA

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Dec 12 2018GHDXGENOMIC HEALTH INCBAKER BROS. ADVISORS LPDirectorSellS73.0915,2431,114,0479,683,7469.7 M to 9.7 M (-0.16 %)
Dec 12 2018GHDXGENOMIC HEALTH INCBAKER BROS. ADVISORS LPDirectorSellS73.092,340171,0211,520,9521.5 M to 1.5 M (-0.15 %)
Dec 12 2018GHDXGENOMIC HEALTH INCBAKER BROS. ADVISORS LPDirectorSellS73.0940329,454295,624296 K to 295.6 K (-0.14 %)
Dec 12 2018GHDXGENOMIC HEALTH INCBAKER BROS. ADVISORS LPDirectorSellS73.0923417,102188,424188.7 K to 188.4 K (-0.12 %)
Dec 12 2018GHDXGENOMIC HEALTH INCBAKER BROS. ADVISORS LPDirectorSellS73.09181,31651,68651.7 K to 51.7 K (-0.03 %)
Dec 12 2018GHDXGENOMIC HEALTH INCBAKER BROS. ADVISORS LPDirectorSellS73.0926219,148205,673205.9 K to 205.7 K (-0.13 %)
Dec 12 2018GHDXGENOMIC HEALTH INCBAKER BROS. ADVISORS LPDirectorSellS71.8112,627906,7979,698,9899.7 M to 9.7 M (-0.13 %)

View all BAKER BROS ADVISORS LLC insider transactions.